Mutant p53 protein localized in the cytoplasm inhibits autophagy

被引:244
作者
Morselli, Eugenia [2 ]
Tasdemir, Ezgi [2 ]
Maiuri, Maria Chiara [2 ,3 ]
Galluzzi, Lorenzo [2 ]
Kepp, Oliver [2 ]
Criollo, Alfredo [2 ]
Vicencio, Jose Miguel [2 ]
Soussi, Thierry [4 ,5 ]
Kroemer, Guido [1 ,2 ]
机构
[1] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France
[2] Univ Paris 11, Orsay, France
[3] Univ Naples Federico II, Fac Sci Biotecnol, Naples, Italy
[4] Univ Paris 06, Paris, France
[5] Canc Ctr Karolinska, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Bcl-2; cancer; GFP-LC3; human colon carcinoma HCT 116 cells; MDM2; p53 hot-spot mutations;
D O I
10.4161/cc.7.19.6751
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The knockout, knockdown or chemical inhibition of p53 stimulates autophagy. Moreover, autophagy-inducing stimuli such as nutrient depletion, rapamycin or lithium cause the depletion of cytoplasmic p53, which in turn is required for the induction of autophagy. Here, we show that retransfection of p53(-/-) HCT 116 colon carcinoma cells with wild type p53 decreases autophagy down to baseline levels. Surprisingly, one third among a panel of 22 cancer-associated p53 single amino acid mutants also inhibited autophagy when transfected into p53(-/-) cells. Those variants of p53 that preferentially localize to the cytoplasm effectively repressed autophagy, whereas p53 mutants that display a prominently nuclear distribution failed to inhibit autophagy. The investigation of a series of deletion mutants revealed that removal of the DNA-binding domain from p53 fails to interfere with its role in the regulation of autophagy. Altogether, these results identify the cytoplasmic localization of p53 as the most important feature for p53-mediated autophagy inhibition. Moreover, the structural requirements for the two biological activities of extranuclear p53, namely induction of apoptosis and inhibition of autophagy, are manifestly different.
引用
收藏
页码:3056 / 3061
页数:6
相关论文
共 38 条
[1]   Inhibition of macroautophagy triggers apoptosis [J].
Boya, P ;
González-Polo, RA ;
Casares, N ;
Perfettini, JL ;
Dessen, P ;
Larochette, N ;
Métivier, D ;
Meley, D ;
Souquere, S ;
Yoshimori, T ;
Pierron, G ;
Codogno, P ;
Kroemer, G .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (03) :1025-1040
[2]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[3]   Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis [J].
Castedo, Maria ;
Coquelle, Arnaud ;
Vitale, Ilio ;
Vivet, Sonia ;
Mouhamad, Shahul ;
Viaud, Sophie ;
Zitvogel, Laurence ;
Kroemer, Guido .
SIGNAL TRANSDUCTION PATHWAYS, PT A: APOPTOTIC AND EXTRACELLULAR SIGNALING, 2006, 1090 :35-49
[4]   DRAM, a p53-induced modulator of autophagy, is critical for apoptosis [J].
Crighton, Diane ;
Wilkinson, Simon ;
O'Prey, Jim ;
Syed, Nelofer ;
Smith, Paul ;
Harrison, Paul R. ;
Gasco, Milena ;
Garrone, Ornella ;
Crook, Tim ;
Ryan, Kevin M. .
CELL, 2006, 126 (01) :121-134
[5]   Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers [J].
Dearth, Lawrence R. ;
Qian, Hua ;
Wang, Ting ;
Baroni, Timothy E. ;
Zeng, Jue ;
Chen, Stephanie W. ;
Yi, Sun Young ;
Brachmann, Rainer K. .
CARCINOGENESIS, 2007, 28 (02) :289-298
[6]   Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis [J].
Degenhardt, Kurt ;
Mathew, Robin ;
Beaudoin, Brian ;
Bray, Kevin ;
Anderson, Diana ;
Chen, Guanghua ;
Mukherjee, Chandreyee ;
Shi, Yufang ;
Gelinas, Celine ;
Fan, Yongjun ;
Nelson, Deirdre A. ;
Jin, Shengkan ;
White, Eileen .
CANCER CELL, 2006, 10 (01) :51-64
[7]   CP-31398 restores DNA-binding activity to mutant p53 in vitro but does not affect p53 homologs p63 and p73 [J].
Demma, MJ ;
Wong, S ;
Maxwell, E ;
Dasmahapatra, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :45887-45896
[8]  
Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.3.CO
[9]  
2-P
[10]  
Galluzzi L, 2008, CURR MOL MED, V8, P78